Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About AAUC Interactive Breakdown Better Bets vs. AAUC Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Allied Gold (AAUC)

Market Price (10/30/2025): $17.3 | Market Cap: $2.0 Bil
Sector: Materials | Industry: Gold

Allied Gold (AAUC)

Market Price (10/30/2025): $17.3
Market Cap: $2.0 Bil
Sector: Materials
Industry: Gold

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 32%		  Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 347x
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 28%		  Not cash flow generative
FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -7.0%
2   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -11%
0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 32%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 28%
2 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 347x
3 Not cash flow generative
FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -7.0%
4 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -11%

Market Valuation & Key Metrics

AAUCS&P 500
REVENUE GROWTHVERY GOOD
Rev LTM ($ Bil)1.0
Rev Chg Q28.8%6.4%
Rev Chg LTM31.8%5.4%
Rev Chg 3Y Avg23.1%5.3%
PROFITABILITYFAIR
Op Inc LTM ($ Bil)0.2
CFO LTM ($ Bil)0.3
Net Inc LTM ($ Bil)-0.1
Op Mgn LTM20.1%18.7%
CFO/Rev LTM28.1%20.4%
Net Inc Mgn-13.4%12.8%
VALUATIONMODERATE
P/S2.03.2
P/CFO7.215.5
P/FCF-28.920.6
P/E-15.223.6
STABILITYVERY GOOD
Debt/Equity0.060.21
Cash/Assets0.150.07

AAUC Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
null

null
null

null
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
AAUC Return------0%
Peers Return38%-9%-6%-3%-0%78%100%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
AAUC Win Rate-----67% 
Peers Win Rate37%35%38%40%37%71% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
AAUC Max Drawdown------ 
Peers Max Drawdown-19%-22%-26%-19%-17%-0% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: B, FNV, FSM, NAMM, NEM.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

AAUC has limited trading history. Below is the Materials sector ETF (XLB) in its place.

Unique KeyEventXLBS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-25.7%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven34.5%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven534 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-37.6%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven60.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven121 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-26.1%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven35.4%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven617 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-60.7%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven154.6%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1761 days1480 days

Compare to


In The Past

Materials Select Sector SPDR's stock fell -25.7% during the 2022 Inflation Shock from a high on 4/20/2022. A -25.7% loss requires a 34.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Allied Gold (AAUC)

Better Bets than Allied Gold (AAUC)

 AAUCBetter Performance than AAUC
MetricValueIndustry (Gold)
Rev Chg LTM31.8%AEM (35.2%), AU (54.6%), CDE (63.7%), IAG (57.8%), NGD (44.2%)
Op Mgn LTM20.1%NEM (43.5%), AEM (49.4%), B (38.7%), FNV (68.3%), AU (36.5%)
CFO/Rev LTM28.1%NEM (42.9%), AEM (55.2%), FNV (88.1%), AU (39.7%), KGC (48.0%)
FCF/Rev LTM-7.0%NEM (28.5%), AEM (34.5%), AU (23.3%), KGC (29.3%), AGI (14.4%)
Total Yield-6.5%NEM (9.2%), AEM (5.1%), B (5.8%), FNV (2.7%), AU (7.5%)
 AAUCBetter Performance than AAUC
MetricValueAll Other Sectors
Rev Chg LTM31.8%NVDA (71.6%), LLY (36.8%), PLTR (38.8%), MU (48.9%), APP (48.2%)
Op Mgn LTM20.1%NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AVGO (39.0%)
CFO/Rev LTM28.1%NVDA (46.6%), MSFT (50.0%), GOOGL (39.3%), AVGO (42.4%), META (56.8%)
FCF/Rev LTM-7.0%NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AMZN (2.0%)
Total Yield-6.5%NVDA (1.8%), AAPL (2.8%), MSFT (3.3%), GOOGL (3.9%), AMZN (3.0%)
 Best Bets In Materials Sector
 AAUCRGLD USLM SCCO CF EXP LIN NEU NEM CBT AXTA
What You Pay           
P/E-15.526.028.031.010.415.530.214.712.68.513.5
P/EBIT346.622.324.218.46.611.321.710.78.65.58.2
What You Get           
Rev Chg Q28.8%20.4%19.6%20.1%20.2%4.3%2.8%0.6%20.0%-9.2%-2.4%
Rev Chg LTM31.8%30.1%22.0%23.2%9.5%0.9%1.3%3.7%26.6%-3.6%-1.8%
Rev Chg 3Y Avg�8.2%19.1%3.3%-12.4%5.6%0.6%4.7%23.9%-2.5%2.7%
FCF/Rev 3Y Avg-10.9%10.2%24.7%23.7%21.3%17.5%15.4%14.0%13.8%8.9%8.0%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 11%, alpha of 1.8%, and sharpe of 0.46

Latest Trefis Analyses

TitleTopic
0DASHBOARDS 
1How Low Can Allied Gold Stock Really Go?Return

Trade Ideas

Select past ideas related to AAUC. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
AXTA_9302025_Dip_Buyer_FCFYield09302025AXTAAxalta Coating SystemsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		3.0%3.0%-7.8%
GPK_9302025_Dip_Buyer_ValueBuy09302025GPKGraphic PackagingDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-16.8%-16.8%-16.8%
FCX_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025FCXFreeport-McMoRanMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		8.0%8.0%-0.9%
KWR_7312025_Dip_Buyer_FCFYield07312025KWRQuaker HoughtonDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		14.5%14.5%0.0%
TGLS_6302025_Quality_Momentum_RoomToRun_10%06302025TGLSTecnoglassQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		-23.1%-23.1%-23.3%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
AXTA_9302025_Dip_Buyer_FCFYield09302025AXTAAxalta Coating SystemsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		3.0%3.0%-7.8%
GPK_9302025_Dip_Buyer_ValueBuy09302025GPKGraphic PackagingDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-16.8%-16.8%-16.8%
FCX_9302025_Monopoly_xInd_xCD_Getting_Cheaper09302025FCXFreeport-McMoRanMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		8.0%8.0%-0.9%
KWR_7312025_Dip_Buyer_FCFYield07312025KWRQuaker HoughtonDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		14.5%14.5%0.0%
TGLS_6302025_Quality_Momentum_RoomToRun_10%06302025TGLSTecnoglassQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run		-23.1%-23.1%-23.3%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Allied Gold

Financials

AAUCBFNVFSMNAMMNEMMedian
NameAllied G.Barrick .Franco-N.Fortuna .Namib Mi.Newmont  
Mkt Price17.4533.06188.908.261.9282.3125.26
Mkt Cap2.056.736.42.5-90.336.4
Rev LTM95813,8241,3341,098-21,5031,334
Op Inc LTM1935,351911322-9,359911
FCF LTM-68--938238-6,12285
FCF 3Y Avg-83-42113-2,63677
CFO LTM269-1,176437-9,224806
CFO 3Y Avg99-1,017324-5,616670

Growth & Margins

AAUCBFNVFSMNAMMNEMMedian
NameAllied G.Barrick .Franco-N.Fortuna .Namib Mi.Newmont  
Rev Chg LTM31.8%16.9%18.1%26.8%-26.6%26.6%
Rev Chg 3Y Avg-5.9%0.7%16.8%-23.9%11.3%
Rev Chg Q28.8%16.4%42.0%47.4%-20.0%28.8%
QoQ Delta Rev Chg LTM6.3%3.9%8.9%7.2%-4.5%6.3%
Op Mgn LTM20.1%38.7%68.3%29.4%-43.5%38.7%
Op Mgn 3Y Avg13.1%29.4%63.5%19.4%-23.9%23.9%
QoQ Delta Op Mgn LTM-2.9%3.2%1.6%2.9%-4.5%2.9%
CFO/Rev LTM28.1%-88.1%39.8%-42.9%41.3%
CFO/Rev 3Y Avg10.9%-82.3%36.2%-32.6%34.4%
FCF/Rev LTM-7.0%--70.3%21.7%-28.5%7.3%
FCF/Rev 3Y Avg-10.9%-6.5%10.5%-13.8%8.5%

Valuation

AAUCBFNVFSMNAMMNEMMedian
NameAllied G.Barrick .Franco-N.Fortuna .Namib Mi.Newmont  
Mkt Cap2.056.736.42.5-90.336.4
P/S2.14.127.32.3-4.24.1
P/EBIT346.69.936.38.1-8.69.9
P/E-15.520.546.416.1-12.616.1
P/CFO7.4-31.05.8-9.88.6
Total Yield-6.5%5.8%2.7%6.2%-9.2%5.8%
Dividend Yield0.0%0.9%0.5%0.0%-1.2%0.5%
FCF Yield 3Y Avg--0.4%5.4%-3.6%3.6%
D/E0.10.00.00.1-0.10.1
Net D/E-0.00.0-0.0-0.1--0.0-0.0

Returns

AAUCBFNVFSMNAMMNEMMedian
NameAllied G.Barrick .Franco-N.Fortuna .Namib Mi.Newmont  
1M Rtn-0.3%0.9%-15.3%-7.8%-41.6%-2.4%-5.1%
3M Rtn35.4%57.4%18.8%28.1%-51.5%33.0%30.5%
6M Rtn-82.0%14.5%38.8%-61.1%50.0%
12M Rtn-68.6%40.0%61.6%-78.9%65.1%
3Y Rtn-136.8%57.8%197.1%-112.8%124.8%
1M Excs Rtn-2.5%-3.6%-16.7%-8.7%-40.9%-5.9%-7.3%
3M Excs Rtn24.5%46.2%7.7%19.9%-64.3%22.6%21.2%
6M Excs Rtn-60.2%-7.2%17.1%-39.4%28.2%
12M Excs Rtn-52.1%23.1%44.2%-56.5%48.1%
3Y Excs Rtn-56.5%-17.5%116.1%-34.0%45.2%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/6/20255/7/20253/31/202511/7/20248/8/20245/9/20243/26/202411/9/20238/8/20245/9/20243/26/202411/9/2023
Key Financials Quarterly            
Total Revenue252346171189196175180177145154190147
Ebitda169335-755229-1-1592261723
Operating Income3497293348223151312118
Net Income-2515-10-1088-65-1951-20-11-5
EPS-0.220.15-0.09-1.290.10-0.060.33-2.940.01-0.24-0.14-0.06
Key Financials TTM            
Total Revenue TTM958902730739727676656666636---
Ebitda TTM69105416-78-108-132-11467---
Operating Income TTM1932071331078954444145---
Net Income TTM-129-95-116-100-187-194-208-225-36---
Growth Rates Quarterly            
Total Revenue Growth28.8%97.9%-4.9%6.9%34.9%13.4%-5.2%20.3%----
EBITDA Growth-69.3%216.7%5130.9%52.6%136.9%400.5%-104.1%-801.1%----
Operating Income Growth-30.4%331.9%765.2%119.6%262.8%91.7%158.9%-17.5%----
Net Income Growth-406.2%366.0%-288.8%44.5%623.5%72.2%148.1%-3865.8%----
Margins Quarterly            
EBITDA Margin6.4%27.0%20.2%-39.8%26.7%16.8%-0.4%-89.9%15.2%3.8%8.7%15.4%
Operating Income Margin13.4%27.9%17.1%17.6%24.7%12.8%1.9%8.6%9.2%7.6%0.7%12.5%
Net Income Margin-10.1%4.4%-6.0%-57.2%4.2%-3.2%3.0%-110.2%0.8%-13.2%-6.0%-3.3%
Cash & Debt            
Total Cash2192322259578125159199--45-
Total Debt12512312812310610411311200540
Net Debt / (Cash)-94-110-972828-22-45-86--8-
Cash Flows Quarterly            
FCF from Operations221215373-6-8-9289723
Cash Flows TTM            
FCF from Operations TTM26924111249-21-7112748---
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC23.3%40.0%23.5%28.4%19.4%22.3%3.6%18.2%--6.2%-
Return on Invested Capital (ROIC) TTM            
ROIC TTM33.4%42.5%26.8%22.9%19.7%13.5%11.6%12.4%----

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity883,879
Short Interest: % Change Since 93020252.0%
Average Daily Volume302,685
Days-to-Cover Short Interest2.92
Basic Shares Quantity113,917,566
Short % of Basic Shares0.8%

Returns Analyses

SEC Filings

Expand for More

Report Date

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.